跳至主要内容
临床试验/KCT0001458
KCT0001458已完成未知

Clinical study for effects on menopasual symtom and blood vessel using combination of Kudzu and foxglove roots extract plus exercise

Ewha Womans University0 个研究点目标入组 150 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
150

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional Study

入排标准

年龄范围
45(Year) 至 60(Year)(—)
性别
Female

入选标准

  • 1) The particioants who give informed consent before the start
  • 2) 45~60 years old
  • 3) Postmenopause (defined as at least 12 months amenorrhoea) or Perimenopause (defined as having no more than one menstrual period during the 3 months before recruitment and having follicle stimulating hormone>40 IU/L) women
  • 4) Women with moderate to severe menopausal symptoms (Kupperman index total score = 20)
  • 5) Fasting LDL-cholesterol level = 130mg/dL
  • 6) Women with low quality of the meal (recommended food score = 36)
  • 7) Fasting blood glucose = 100 mg/dl
  • 8) glycated hemoglobin (HbA1c) = 5.7% and = 6.4%
  • 9) BMI: = 23kg/m2

排除标准

  • 1) Subjects who performed constant exercises at least 3 months prior to the first visit
  • 2) Subjects who cannot participate in an exercise program
  • 3) Subjects with surgical or chemotherapy induced menopause 4) Subjects who have a history of breast cancer orabnormality depicted on a mammogram5) Subjects who received hormone therapy within 6 months before the first visit
  • 6) Subjects who take excessive amount of isoflavones (=56 mg/day)
  • 7) Subjects who consumed the functional food within 4 weeks prior to the first visit
  • 8) Subjects who took medical supplies within 4 weeks prior to the first visit : Sleep iaid drug, antidepressant,selective estrogen receptor modulator, hypocholesterolemic drug, antihypertensive drugs, antidiabetes drugs, bisphosphonate, calcitonin
  • 9) Subjects who have been vaginal bleeding without diagnosis
  • 10) Subjects who have a history of endometrial hyperplasia, endometrial cancer, sex steroid dependant organ tumors
  • 11) Subjects who have a history of severe migraine, thromboembolism, cerebrovascular disease, cardiovascular disease within 1 year prior to the first visit
  • 12) Subjects with hepatic or renal dysfunction (aspartate aminotransferase (AST) or alanine aminotransferase (ALT) level > 2 times the upper limit of normal, Creatinine > 2.0 mg/dL)
  • 13) Hypertensive subjects Systolic blood pressure(SBP)/Diastolic blood pressure(DBP) = 140/90 mmHg), subjects with thyroid disease (thyroid stimulating hormone(TSH)<0.55 uIU/mL or >4.78uIU/mL), diabetes, subjects with hyperlipidemia
  • 14) drug addicts or alcoholics
  • 15) Subjects sensitive to test materials
  • 16) Subjects who has participated in another investigational study within 4 weeks prior to the first visit

研究者

相似试验